INTRODUCTION
============

Cardiac implantable electronic devices (CIEDs) are an essential part of cardiologic treatment in high-risk patients with a wide range of structural or functional heart diseases \[[@B1][@B2]\]. Over the last few decades, numerous procedural changes have been made in pacemaker implantation, mostly attributable to technological advancements throughout multiple generations of the devices \[[@B3]\]. The size of the pulse generators has also decreased over time, making it possible, most notably in pediatric patients, to replace abdominal implantation of an epicardial pacemaker with an endocardial device in the prepectoral or subpectoral space.

The clinical use of CIEDs has expanded to include not only middle-age patients with chronic conditions, but also younger patients predisposed to sudden cardiac death. However, several problems have arisen with conventional subcutaneous device insertion in the subclavian area, most notably the conspicuous contour of the pacemaker in the subcutaneous pocket of the anterior chest and/or an often unsightly surgical scar ([Fig. 1](#F1){ref-type="fig"}) \[[@B4]\].

With this problem in mind, a collaborative team of cardiologists and plastic surgeons in our institution developed a technique for the subpectoral placement of CIEDs in young female patients via a transaxillary approach. This transaxillary approach has been frequently utilized in augmentation mammoplasty to hide visible operative scars in the axillary fold, and therefore our procedure can be deemed an extension of a familiar surgical approach for a different purpose. We present our experience with this procedure in 10 young female patients, including 1 patient who received augmentation mammoplasty together with CIED placement.

METHODS
=======

Patients
--------

From July 2012 to December 2015, subpectoral CIED placement via the transaxillary approach was performed in 10 young female patients who were referred from a group of 3 cardiologists at our institution ([Table 1](#T1){ref-type="table"}).

All subjects were young and lean female patients with a mean age of 25.9 years (range, 16--38 years) and a mean body mass index (BMI) of 20.1 kg/m^2^ (range, 17.44--23.28 kg/m^2^). The mean postoperative follow-up period was 88.2 weeks.

The patients had been diagnosed with a range of anatomical and functional cardiac abnormalities. Five patients had been diagnosed with various types of cardiomyopathy, of whom 3 had dilated cardiomyopathy, 1 had chemotherapy-induced cardiomyopathy, and 1 patient had hypertrophic cardiomyopathy. Three patients had symptomatic sick sinus syndrome. Two patients had high-degree atrioventricular block, and 1 patient had ventricular fibrillation.

All patients were highly concerned with any noticeable physical changes on their chest following the CIED insertion, and they wanted any surgical scar to be concealed as much as possible. One patient with dilated cardiomyopathy inquired about the possibility of combining augmentation mammoplasty using the conventional endoscopic approach and CIED insertion under the same subpectoral plane, and we carried out a combination of these 2 procedures in that patient.

Each patient was informed that the inserted device would require a battery change every 10 years at the time of battery depletion, and that the same subpectoral plane would be used again during each of these future procedures.

We also reviewed all surgical complications that could lead to device removal, such as postoperative pain, device migration, lead dislodgement, and infection.

Surgical technique
------------------

All patients were under general anesthesia throughout the entire surgical procedure. In the supine position, the patient\'s shoulder was abducted to expose the axillary area and the lateral border of the pectoralis major muscle. On the axillary fossa, a linear incision approximately 5--7 cm in length was made along one of the deepest axillary creases, mostly perpendicular to the lateral border of the pectoralis major. Care was taken not to extend this incision beyond the anterior axillary fold. The subcutaneous dissection proceeded, with undermining remaining close to the lateral border of the pectoralis major muscle, since major neurovascular structures are located posteriorly under the axillary fat pad. The scrub assistants, if any, should be informed not to retract the lateral tissue too strongly, because this can stretch the intercostobrachial nerve and the patient may complain of numbness of the upper medial aspect of the affected arm after surgery.

When the fascia of the pectoralis major was encountered at its lateral border, the submuscular plane was identified while maintaining intact attachment of the pectoralis minor muscle to the chest wall. The clavipectoral fascia enclosing the pectoralis minor muscle can be readily differentiated from the pectoral fascia of the pectoralis major. The dissection continued over the clavipectoral fascia; otherwise, further dissection under the pectoralis minor may damage vital structures, such as the thoracoacromial artery, cephalic vein, or lateral pectoral nerve, which may appear beyond the muscle. The medial pectoral nerve mainly supplies the pectoralis minor and partly the pectoralis major, and it may also be exposed and inadvertently damaged during undermining. This alone, however, would not result in significant functional sequelae. Under the submuscular plane of the pectoralis major, dissection is relatively easy without being disturbed by arterial perforators, and the surgeon continued until a pocket became large enough to securely receive a cardiac pulse generator. Slight upward dissection also exposed an entrance window to the subclavian vein, allowing the cardiology team to easily gain access to the vein ([Fig. 2](#F2){ref-type="fig"}).

Using the Seldinger technique, the subclavian vein was punctured, and a cardiologist introduced the ventricular lead and, if necessary, an atrial lead via a 9-Fr guiding sheath while stably anchoring them on the right ventricular apex and right atrial appendage, respectively. The ventricular and atrial leads were then connected to a pulse generator, and device function was evaluated using wireless telemetry with the device in place. The device was then stably fixed onto either the periosteum of the rib bone or the outermost fascia of the intercostalis muscle with absorbable sutures, and 1 or 2 other additional sutures were made into the surrounding tissues ([Fig. 3](#F3){ref-type="fig"}). A negative-pressure drain was inserted, and the subcutaneous tissue was repaired in layers, first with absorbable sutures and then with nonabsorbable sutures for skin closure ([Fig. 4](#F4){ref-type="fig"}).

Blood pressure and other signs of hemodynamics should be carefully monitored during the entire procedure, particularly while the patient is sitting up for an evaluation of the shape and position of the implants.

Postoperative pain was usually not remarkable, and analgesia use was similar to or less than that observed in patients who undergo augmentation mammoplasty. We maintained negative-pressure drains until the daily amount of drainage became less than 20 mL.

RESULTS
=======

Cardiac implantable electronic devices
--------------------------------------

All patients were treated with subpectoral CIED insertion at a single institution by 2 plastic surgeons in collaboration with 3 cardiologists ([Table 1](#T1){ref-type="table"}). Four patients received pacemakers, 5 received implantable cardioverter defibrillators (ICDs), and 1 patient was treated with a cardiac resynchronization therapy defibrillator.

Patient satisfaction
--------------------

In general, all patients were highly satisfied with the outcomes. They responded with an average of 8.5 points on a scale of 1 to 10 when asked about how much they were pleased with the benefits of the transaxillary procedure. Some patients complained of minor discomfort, such as temporary hypoesthesia on and around the incision area. Some did not like the fact that they were required to limit their arm movements for the first few postoperative weeks. However, all patients said that they would recommend this procedure to others of the same age with similar cardiac conditions.

Complications
-------------

One case of device pocket infection occurred. A bacterial swab culture and subsequent blood culture revealed methicillin-resistant *Staphylococcus aureus*. The device was ultimately surgically removed. One month after device removal, when the inflammation had subsided completely, a new device was inserted into the right anterior chest wall using the conventional subcutaneous plane.

Another patient experienced mild tingling on the medial aspect of the right upper arm, which resolved spontaneously within several weeks. No other significant complications were found in the other patients.

DISCUSSION
==========

As implantable cardioverter defibrillators have become a mainstay of antiarrhythmic treatments for the primary and secondary prevention of sudden cardiac death, providing substantial benefits in terms of utility, efficacy, and safety \[[@B1][@B2][@B5]\], several researchers have investigated the quality of life among recipients of these devices \[[@B6][@B7]\]. Moreover, the indications for CIEDs are expanding to include younger patients, with the early recognition of inherited cardiac syndromes, such as long QT syndrome, Brugada syndrome, and hypertrophic cardiomyopathy.

Once implanted, CIEDs should be maintained for the rest of the patient\'s life, and the physical and psychological impact can therefore be much greater among young patients. In addition, these patients will experience psychological discomfort if visible scars and bulging of the device are not addressed properly, leading to a more intense need to alleviate the stigma experienced by patients.

The psychosocial impact of CIEDs can be of particular concern, making young female patients most vulnerable. Vazquez reported that younger female patients showed worse perceptions of shock anxiety, death anxiety, and body image distress than older female patients \[[@B4]\]. In 2012, Marshall et al. \[[@B8]\] reported that female patients were more distressed than male patients about the impact of CIEDs on their appearance, especially women younger than 39 years of age. Earlier research also revealed that younger CIED patients had concerns about various issues, such as the fit of clothing, socialization, and sexual activity.

The conventional technique, which involves a subclavian skin incision with subcutaneous pocket formation, fails to address these quality of life issues. CIED recipients have often been stigmatized due to the operative scar in the infraclavicular area, which is highly susceptible to hypertrophic scarring, because unusual tension is applied due to the convexity of the chest wall and weight of the breast. The superficial placement of the device also involves a greater risk of skin ulceration or device exposure.

Several alternative surgical approaches, therefore, have been suggested in response to these problems. A surgical approach through the inframammary fold was the first alternative route described in the literature in an effort to place the pacemaker or CIED behind the breast tissue or pectoralis major muscle. In 1983, Belott and Bucko \[[@B9]\] first presented his experience with 2 female patients utilizing an inframammary approach for pacemaker placement. Allan \[[@B10]\], in 1985, published a case report describing his use of the familiar inframammary approach employed in augmentation mammoplasty to implant a pacemaker. In 1993, Kolettis et al.\[[@B11]\] reported successful retromammary CIED device placement with an endocardial lead system in a 62-year-old woman. These early attempts were done exclusively using a subglandular pocket, followed by Ozin et al. \[[@B12]\] and Schaverien et al. \[[@B13]\].

Giudici \[[@B14]\] and Collegues \[[@B15]\], in 2001 and 2010, published his comprehensive experience with the subpectoral placement of pacemakers and CIEDs in 51 female patients over a 9-year period. He used the subpectoral plane to place the devices with the skin incision on the inframammary fold for device insertion and a separate 15--20-mm incision on the anterior axillary line for lead insertion. Patient satisfaction was high, and 3 cases of lead dislodgement and 1 case of pneumothorax were reported as complications. Persichetti also presented, in 2014, 30 consecutive female patients who underwent submuscular implantation or substitution of CIED devices, which was the largest clinical series for submuscular ICD implantation \[[@B16]\]. The inframammary approach leads to excellent cosmetic results, since the operative scar is seen only when the patient raises her arm. However, as a 2-incision method, it still requires another skin incision in the infraclavicular area for lead insertion and narrow subcutaneous tunneling to the device pocket behind the breast.

Other alternative routes include subpectoral placement via a conventional infraclavicular incision. In 1992, Hammel et al. \[[@B17]\] inserted a CIED under the pectoralis major with a cephalic venotomy incision in an obese woman. In 2014, Asamura et al. \[[@B18]\] presented results from 21 male patients for the secondary replacement of CIED devices; by using the previous operative scar in the infraclavicular area, he inserted the devices under the pectoralis major muscle by splitting the muscle fibers between the clavicular and sternocostal attachment points. Half of the patients were lean, with a BMI under 18.5 kg/m^2^, and the bulge from the device became much smoother after the procedure than is the case for conventional subcutaneous pockets, although an infraclavicular scar was still obvious.

A skin incision via the lateral border of the pectoralis muscle was also utilized by several researchers, particularly among pediatric patients. Molina \[[@B19]\], in 1991, published his long-term experience with 83 adult female patients and 21 pediatric patients. Two skin incisions, a short subclavian puncture and a longer lateral breast incision, were used to insert the device in the subglandular pocket in female patients. Several other reports of subpectoral pacemaker insertion for pediatric patients were published by Shefer et al. \[[@B20]\] in 1996 and Rosenthal \[[@B21]\] in 2000, using a direct skin incision along the lateral border of the pectoralis major. However, this operative scar on anterior axillary fold was still readily visible upon even slight arm abduction.

Despite the variety of these previous approaches, we believe that the transaxillary approach is the most suitable method for young female patients. It can effectively conceal the operative scar in the axillary fossa, as it can be disguised between natural axillary creases, as long as the operator does not extend the incision anteriorly beyond the anterior axillary fold. The bulge from the device is hardly noticeable, allowing the patients to continue their normal lives without continuously paying attention to the existence of the cardiac device ([Fig. 5](#F5){ref-type="fig"}). This approach may eliminate even the small inconveniences in daily life caused by the bulge of the device when wearing a seatbelt or carrying a bag with shoulder straps.

The young female patients in our study also showed a high level of satisfaction regarding the benefits and outcomes of the procedure, and unanimously said that they would recommend this transaxillary subpectoral approach to those in similar circumstances.

This approach is already time-tested in cosmetic plastic surgery with regard to operative scar management. Moreover, it does not necessitate a separate skin incision in the infraclavicular area, since the subclavian vein can also be approached via a single axillary incision. An additional skin stab incision, no matter how short it may be, can be a psychological burden for the patient if it is located in a potentially visible area.

The transaxillary approach is not regarded as a technically demanding task for a plastic surgeon. When performing cosmetic augmentation mammoplasty, bleeding from perforators can be troublesome given the limited surgical field, but the subpectoral pocket for CIED placement is laterally positioned and small, such that medial perforators are rarely encountered. Plastic surgeons should not find it difficult to implement this transaxillary CIED placement procedure, since it is a simpler form of an already familiar approach, only for a different purpose.

Our first patient experienced bacterial infection inside the device pocket, and the CIED eventually had to be removed. However, we encountered no other complications, such as device dislocation, lead dislodgement, or pneumothorax. Device dislocation is a very unlikely occurrence, since the device is fixated with absorbable sutures tightly onto the chest wall fascia or periosteum through a separate hole at the corner of the pulse generator device. Shoulder movement is also restricted for the first 2 postoperative weeks, leaving the device unaffected by pectoralis major muscle contraction, which may potentially dislocate the device to an unfavorable position.

The device must be periodically replaced upon battery depletion multiple times throughout the patients\' lives. As the device in the subpectoral space sits comfortably inside a fibrous capsule by the time it is about to run out of battery, theoretically after 10 years, battery exchange can be readily performed by opening the encapsulated pocket and removing the previous device after disconnecting it from the previous leads. The leads can be used permanently, so only the pulse generator device should be exchanged and functionally tested before reinstallation. The device pocket is located at approximately the mid-clavicular level, so the dissection does not have to be deeper or more extensive than the initial procedure.

A transaxillary approach is most appropriate when a lean female patient is considering augmentation mammoplasty. One patient in this study requested a concurrent procedure combining both CIED placement and augmentation mammoplasty, and showed a successful result, with minimal bulging of the device and no additional cardiologic risk. When the procedure is combined with augmentation mammoplasty, the surgical approach is largely identical, as the mammary implants are inserted under the same submuscular plane, but the pocket of the breast implant can be distinguished from that of the more superiorly positioned CIED. The pocket dissection should not be too extensive compared with the size and shape of the cardiac device and breast implant. Otherwise, the breast implant becomes susceptible to gradual migration.

Despite the benefits of the transaxillary approach for subpectoral placement, not all medical centers may be able to perform this procedure, since it requires a certain degree of dedication from cardiologists and plastic surgeons alike. For cardiologists, the use of a transaxillary approach in the subpectoral plane utilizes a completely different set of procedures, so they should not be expected to learn this approach in a center without plastic surgeons. This technique can be made possible by the collaborative efforts of dedicated cardiologists and plastic surgeons.

To date, this is the largest clinical series to be published on the subpectoral placement of CIEDs via a transaxillary approach, which results in superior aesthetic outcomes compared to conventional methods, because this approach is an effective, single-incision method to obscure operative scars and minimize bulging of the device. Patients do not have to be aware of the device at all times, and they can remain as socially active as before the procedure. Young female or lean patients are specific subgroups that would benefit the most from this approach.

This study was presented at the Sixth Research and Reconstructive Forum of the Korean Society of Plastic Surgeons on April 7th, 2016 in Daegu, Korea.
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![Cardiac device in a conventional subclavian pocket\
Conspicuous scarring and disfiguring bulging often result from the conventional subcutaneous insertion of cardiac implantable electronic devices in the subclavian area.](aps-44-34-g001){#F1}

![Device positioning using the transaxillary approach\
The device is placed inside the subpectoral pocket along the mid-clavicular level, and is fixated with absorbable sutures onto the chest wall. A slight upward dissection provides a window to the subclavian vein through which the atrial and ventricular leads are introduced.](aps-44-34-g002){#F2}

![Pulse generator in the subpectoral pocket\
Intraoperative view of an implantable cardioverter-defibrillator pulse generator inside the subpectoral pocket placed via the transaxillary approach.](aps-44-34-g003){#F3}

![Immediate postoperative view of the axillary area\
Immediate postoperative view after negative-pressure drainage insertion and wound closure. Note that the axillary incision did not extend beyond the anterior axillary fold.](aps-44-34-g004){#F4}

![Postoperative results of the transaxillary technique\
(A, B) Eight-month postoperative views of a lean 25-year-old female patient (body mass index, 18.37 kg/m2) with hypertrophic cardiomyopathy who underwent subpectoral placement of a cardiac implantable electronic device. A slight bulge of the device can be palpated on her left anterior chest wall, but almost unrecognizable by others. (C, D) Flat and linear operative scars can be observed only if the arm is raised well over 90°. (E, F) Two-month postoperative chest X-ray images showing no evidence of device migration.](aps-44-34-g005){#F5}

###### Patient demographics, cardiologic indications for CIED implantation with device information, and postoperative follow-up periods

![](aps-44-34-i001)

  Patient no.   Age (yr)   Height (cm)   Weight (kg)   BMI (kg/m^2^)   Symptom (s)                     Indication                                    Device      Model, company, and country                     Follow-up (wk)
  ------------- ---------- ------------- ------------- --------------- ------------------------------- --------------------------------------------- ----------- ----------------------------------------------- ----------------
  1             38         151.6         53.5          23.28           Palpitation, chest discomfort   Sick sinus syndrome                           Pacemaker   Evia, Biotronik, Germany                        214.4
  2             29         166           55            19.96           Sudden cardiac arrest           Ventricular fibrillation                      ICD         Incepta ICD, Boston Scientific, United States   130.4
  3             34         155           51            21.09           Syncope                         Dilated cardiomyopathy                        ICD         Ellipse DR, St. Jude Medical, United States     126.0
  4             16         162           49            18.67           Sudden cardiac arrest           Dilated cardiomyopathy                        ICD         Ellipse DR, St. Jude Medical, United States     76.0
  5             22         151           51.9          22.49           Dizziness                       Chemotherapy-induced dilated cardiomyopathy   CRT-D       VivaQuad XT CRT-D, Medtronic, Ireland           65.4
  6             37         154           48            20.24           Syncope                         High-degree atrioventricular block            Pacemaker   Accolade EL, Boston Scientific, United States   59.1
  7             18         160           48.3          18.75           Syncope                         Sick sinus syndrome                           Pacemaker   Accolade EL, Boston Scientific, United States   57.4
  8             25         153           43            18.37           Syncope                         Hypertrophic cardiomyopathy                   ICD         Evera MRI XT DR, Medtronic, Ireland             32.4
  9             20         0162.1        53            20.17           Dyspnea, dizziness              High-degree atrioventricular block            Pacemaker   Advisa DR MRI, Medtronic, Ireland               36.3
  10^a)^        20         161           45.2          17.44           Dyspnea                         Dilated cardiomyopathy                        ICD         Ellipse DR, St. Jude Medical, United States     84.1
  Mean          25.9       157.6         49.8          20.05           \-                              \-                                            \-                                                          88.2

CIED, cardiac implantable electronic device; BMI, body mass index; ICD, implantable cardioverter-defibrillator; CRT-D, cardiac resynchronization therapy defibrillator.

^a)^A patient who received concomitant augmentation mammoplasty together with CIED placement.
